[HTML][HTML] Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer
K Yuan, Z Li, W Kuang, X Wang, M Ji, W Chen… - Nature …, 2022 - nature.com
Prostate cancer (PCa) is one of the most prevalent cancers in men worldwide, and hormonal
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer.
K Yuan, Z Li, W Kuang, X Wang, M Ji… - Nature …, 2022 - europepmc.org
Prostate cancer (PCa) is one of the most prevalent cancers in men worldwide, and hormonal
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer
K Yuan, Z Li, W Kuang, X Wang, M Ji… - Nature …, 2022 - ui.adsabs.harvard.edu
Prostate cancer (PCa) is one of the most prevalent cancers in men worldwide, and hormonal
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
[PDF][PDF] Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer
K Yuan, Z Li, W Kuang, X Wang, M Ji, W Chen, J Ding… - academia.edu
Results Highly expressed DYRK2 was a potential target in PCa. To investigate the role of
DYRK2 in PCa, we first mined The Cancer Genome Atlas (TCGA) to analyze the expression …
DYRK2 in PCa, we first mined The Cancer Genome Atlas (TCGA) to analyze the expression …
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer.
K Yuan, Z Li, W Kuang, X Wang, M Ji… - Nature …, 2022 - search.ebscohost.com
Prostate cancer (PCa) is one of the most prevalent cancers in men worldwide, and hormonal
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer
K Yuan, Z Li, W Kuang, X Wang, M Ji… - Nature …, 2022 - ideas.repec.org
Prostate cancer (PCa) is one of the most prevalent cancers in men worldwide, and hormonal
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer
K Yuan, Z Li, W Kuang, X Wang, M Ji… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PCa) is one of the most prevalent cancers in men worldwide, and hormonal
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer
K Yuan, Z Li, W Kuang, X Wang, M Ji… - Nature …, 2022 - econpapers.repec.org
Prostate cancer (PCa) is one of the most prevalent cancers in men worldwide, and hormonal
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
[HTML][HTML] Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer
K Yuan, Z Li, W Kuang, X Wang, M Ji… - Nature …, 2022 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is one of the most prevalent cancers in men worldwide, and hormonal
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …
therapy plays a key role in the treatment of PCa. However, the drug resistance of hormonal …